INOZYME PHARMA, INC. Asset Impairment Charges
INOZYME PHARMA, INC. reported Asset Impairment Charges of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2025-03-10
- INOZYME PHARMA, INC. asset impairment charges for fiscal 2024 was $0.00.
- INOZYME PHARMA, INC. asset impairment charges for fiscal 2023 was $0.00.
- INOZYME PHARMA, INC. asset impairment charges for fiscal 2022 was $0.00.
- INOZYME PHARMA, INC. asset impairment charges for fiscal 2021 was $0.00.
| Period end | Asset Impairment Charges 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-10 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-10 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-12 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-22 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-25 |